Actively Recruiting
Feasibility of Examining Acute Responses to Exercise in Symptomatic Females and Males With Atrial Fibrillation: a Pilot Randomized Crossover Study
Led by Ottawa Heart Institute Research Corporation · Updated on 2026-05-06
36
Participants Needed
1
Research Sites
N/A
Total Duration
On this page
AI-Summary
What this Trial Is About
Researchers are studying people with symptomatic atrial fibrillation (AF), including both paroxysmal and persistent types, to see how short-term exercise affects their AF symptoms. This pilot randomized crossover study compares symptom changes during a week of moderate-intensity continuous training (MICT) or high-intensity interval training (HIIT) with a week of no moderate to vigorous exercise. The goal is to understand how exercise acutely influences AF symptoms, especially noting differences between females and males. Participants will take part in three different 7-day periods: one with moderate-intensity continuous exercise, one with high-intensity interval training, and one without moderate to vigorous exercise. During each exercise week, participants will complete three exercise sessions. The study uses a wireless four-finger AliveCor KardiaMobile ECG device to monitor AF status daily. Participants also report symptoms using a 7-day questionnaire during each period. Throughout the study, researchers will check how feasible it is to conduct this crossover trial by tracking recruitment, consent, participant adherence, retention, eligibility adjustments, and any adverse events over about 1.5 years. Participants will have their AF symptoms and heart activity monitored closely during each week. The total observation includes three weeks for the exercise and control conditions, with ongoing safety and study progress evaluations.
CONDITIONS
Brief Title
Acute Responses to Exercise in Females and Males With Symptomatic Atrial Fibrillation
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Diagnosis of paroxysmal or persistent atrial fibrillation
- Resting ventricular rate less than 110 beats per minute
- Able to perform a symptom-limited exercise test
- At least 40 years of age
- Self-reported symptoms of atrial fibrillation in the past 4 weeks
- If female, self-reported post-menopausal status
- Able to read and understand English or French
- Willing to sign informed consent
You will not qualify if you...
- Currently participating in routine exercise training
- Unstable angina or uncontrolled diabetes mellitus
- Severe mitral or aortic stenosis or hypertrophic obstructive cardiomyopathy with significant obstruction
- Unable to access the Internet or a phone (iOS 10.0+ or Android 6.0+ required) during the study
- Has an automated external defibrillator, implantable cardioverter defibrillator, or other pacemaker
- Unwilling or unable to complete all three study conditions
- Unable to provide written informed consent
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - 3 weeks (1 week per condition)
Participants will engage in three sessions of moderate-intensity continuous training (MICT), high-intensity interval training (HIIT), or abstain from moderate- to high-intensity exercise over separate 7-day periods to measure acute responses to exercise.
Daily symptom recording and ECG measurements during each 7-day period
Trial Site Locations
Total: 1 location
1
University of Ottawa Heart Institute
Ottawa, Ontario, Canada, K1Y4W7
Actively Recruiting
Research Team
M
Matheus Mistura
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
CROSSOVER
Primary Purpose
TREATMENT
Number of Arms
3
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here